Abstract A series of novel 6-(6-alkoxy-2-naphthyl) oxoalkanoates and alkanamides were synthesized as inhibitors of inflammation and 5-lipoxygenase. They were evaluated in vivo for anti-inflammatory activity in the established adjuvent arthritis assay in rats and in vitro as inhibitors of 5-lipoxygenase in rat basophilic leukemia (RBL) cells. N-Hydroxy-N-methyl-6-(6- methoxy-2-naphthyl)-6-oxohexanamide, compound 28, which is representative of the ...